Clinical Trial

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Clinical Study to Evaluate the Efficacy and Safety of RSS0393 Ointment in Adult Patients With Plaque Psoriasis.

Name: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Clinical Study to Evaluate the Efficacy and Safety of RSS0393 Ointment in Adult Patients With Plaque Psoriasis. — clinical trial record (NCT07543224)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

Phase III Efficacy and Safety Study of RSS0393 Ointment in Plaque Psoriasis.

Trial Details

NCT Number	NCT07543224
Lead Sponsor	Reistone Biopharma Company Limited
Conditions	Plaque Psoriasis Subjects
Enrollment	600 participants
Start Date	2026-04
Primary Completion	2027-01 (estimated)
Study Completion	2027-12 (estimated)
Updated on ClinicalTrials.gov	2026-04-21